National Association of Testing Authorities, Australia
Scope of Accreditation
CSIRO - Australian Centre for Disease Preparedness (ACDP)
Site
Australian Animal Health Laboratory
Accreditation No.
13546
Site No.
13539
Date of Accreditation
17 Feb 1999
Contact
Availability
Services available to external clients
Supervision
Veterinarian Supervised Laboratory
Scope of Accreditation
ISO/IEC 17025 (2017)
Infrastructure and Asset Integrity
Service | Product | Determinant | Technique | Procedure | Limitations |
---|---|---|---|---|---|
Evaluation of air control equipment | Biological safety cabinets | Work zone integrity | Not applicable | AS 1807.5:2000; AS 1807 Clause 4.3 | for compliance with: AS 2252.2 |
Air barrier containment | Cold DOP | AS 1807.22:2000; AS 1807 Clause 4.9 | for compliance with: AS 2252.2 | ||
Integrity of HEPA filter installations | Cold DOP | AS 1807.7:2000 | not terminally mounted for compliance with: AS 2252.2 | ||
Air flow direction and visualization | Cold DOP | AS 1807.1:2000; AS 1807 Clause 4.1 | for compliance with: AS 2252.2 | ||
Integrity of HEPA filter installations | Cold DOP | AS 1807.6:2000; AS 1807 Clause 4.4 | for compliance with: AS 2252.2 | ||
Clean rooms, pharmaceutical isolators and work stations | Air barrier containment | Cold DOP | AS 1807.22:2000; AS 1807 Clause 4.9 | for compliance with: AS 2252.2 | |
Integrity of HEPA filter installations | Cold DOP | AS 1807.7:2000 | not terminally mounted for compliance with: AS 2252.2 | ||
Work zone integrity | Not applicable | AS 1807.5:2000; AS 1807 Clause 4.3 | for compliance with: AS 2252.2 | ||
Integrity of HEPA filter installations | Cold DOP | AS 1807.6:2000; AS 1807 Clause 4.4 | for compliance with: AS 2252.2 | ||
Air velocity and uniformity of air velocity | Cold DOP | AS 1807.1:2000; AS 1807 Clause 4.1 | for compliance with: AS 2252.2 | ||
Fume cupboards and recirculating fume cabinets | Extraction performance | Face velocity | AS/NZS 2243.8 Appendix B; AS/NZS 2243.9 Appendix B | for compliance with: AS/NZS 2243.8, AS/NZS 2243.9 | |
Extraction performance | Smoke visualisation | AS/NZS 2243.8 Appendix A; AS/NZS 2243.9 Appendix A | for compliance with: AS/NZS 2243.8, AS/NZS 2243.9 |
ISO/IEC 17025 (2017)
Animal Health
Service | Product | Determinant | Technique | Procedure |
---|---|---|---|---|
Detection and identification of virusesFor aquatic animals | Tissues | White spot syndrome virus (WSSV) | PCR - Quantitative (qPCR); Polymerase chain reaction (PCR) | in-house method TM-175 |
Aquabirnaviruses; Aquareoviruses; Aquatic virus; Epizootic haematopoitic necrosis virus; Infectious haematopoietic necrosis virus; Infectious pancreatic necrosis virus; Infectious salmon anemia virus (ISAV); Koi herpes virus (KHV); Nervous necrosis virus (NNV, Betanodovirus); Orthomyxo-like viruses; Red sea bream iridovirus; Salmonid alphavirus; Spring viraemia of carp virus (SVCV); Viral haemorrhagic septicaemia virus; Identification of unknown viruses | Cell culture | in-house method TM-178 | ||
Ostreid herpes virus 1 | PCR - Quantitative (qPCR); Polymerase chain reaction (PCR) | in-house method TM-176 | ||
Abalone herpes virus | PCR - Quantitative (qPCR); Polymerase chain reaction (PCR) | in-house method TM-177 |
ISO/IEC 17025 (2017)
Animal Health
Service | Product | Determinant | Technique | Procedure |
---|---|---|---|---|
Detection and identification of bacteria | Bacterial isolates | Salmonella spp. | MALDI-TOF | in-house method TM-214 |
Identification of unknown bacteria | MALDI-TOF | in-house methods TM-050; TM-214 | ||
Detection and identification of bacteriaFor companion animals, production animals, production avian species, laboratory animals, zoo animals, wildlife, aquatic animals, equine species and avian species | Bacterial isolates | Salmonella spp.; Streptococcus spp. | Macroscopic agglutination | in-house method TM-050 |
Detection and identification of bacteriaFor companion animals, production animals, production avian species, zoo animals, wildlife, aquatic animals, equine species and avian species | Clitoral samples; Fluids; Preputial swabs; Semen; Swabs; Tissues; Urethral swabs | Contagious equine metritis (Taylorella equigenitalis); Identification of unknown bacteria | Biochemical; Commercial identification kit; Cultural; Microscopic examination; Staining | in-house method TM-050 |
Detection and identification of bacteriaFor companion animals, production animals, production avian species, zoo animals, wildlife, equine species and avian species | Abscesses; Aspirates; Effusions; Fluids; Parenchymatous organs; Pus; Tissues | Actinobacillus spp.; Actinomyces spp.; Bacteroides spp.; Clostridium spp.; Corynebacterium spp.; Escherichia coli; Fusobacterium spp.; Haemophilus spp.; Nocardia spp.; Pasteurella spp.; Peptostreptococcus spp.; Pseudomonas spp.; Staphylococcus spp.; Streptococcus spp.; Identification of unknown bacteria | Biochemical; Commercial identification kit; Cultural; Microscopic examination; Staining | in-house method TM-050 (General) |
Bacterial isolates | Brucella biotype; Salmonella serotype | Serum agglutination | in-house method TM-050 | |
Brucella abortus; Brucella canis; Brucella melitensis; Brucella ovis; Brucella suis | Biochemical; Cultural; Microscopic agglutination; Serotyping; Staining | in-house method TM-004 | ||
Bone; Swabs; Synovial fluid | Actinobacillus spp.; Erysipelothrix spp.; Escherichia coli; Haemophilus spp.; Pasteurella spp.; Staphylococcus spp.; Streptococcus spp.; Identification of unknown bacteria | Biochemical; Commercial identification kit; Cultural; Microscopic examination; Staining | in-house method TM-050 (Skeletal) | |
Brain tissue; Cerebrospinal fluid (CSF); Conjunctiva; Corneal material; Spinal cord | Chlamydia spp.; Escherichia coli; Histophilus somni (Histophilus ovis); Listeria spp.; Moraxella bovis; Moraxella ovis; Nocardia spp.; Pasteurella spp.; Streptococcus spp. | Biochemical; Commercial identification kit; Cultural; Microscopic examination; Staining | in-house method TM-050 (Nervous) | |
Bronchial washings; Lung; Swabs; Tracheal washes | Actinobacillus spp.; Actinomyces spp.; Bordetella spp.; Corynebacterium spp.; Escherichia coli; Haemophilus spp.; Klebsiella spp.; Mycobacterium spp.; Nocardia spp.; Pasteurella spp.; Staphylococcus spp.; Streptococcus spp. | Biochemical; Commercial identification kit; Cultural; Microscopic examination; Staining | in-house method TM-050 (Respiratory) | |
Ear swabs; Scrapings; Skin; Swabs | Actinomyces spp.; Corynebacterium spp.; Nocardia spp.; Pityrosporum canis; Pseudomonas spp.; Staphylococcus spp.; Streptococcus spp.; Identification of unknown bacteria | Biochemical; Commercial identification kit; Cultural; Microscopic examination; Staining | in-house method TM-050 (Integumentary) | |
Faeces; Gastrointestinal tract specimens; Intestinal contents | Clostridium perfringens; Escherichia coli; Mycobacterium paratuberculosis (Johne's disease); Salmonella enterica serovar Gallinarum biovar Pullorum; Salmonella enterica serovar Typhimurium; Salmonella spp.; Shigella spp.; Identification of unknown bacteria | Biochemical; Commercial identification kit; Cultural; Microscopic examination; Staining | in-house method TM-050 (Faecal) | |
Faeces; Intestinal contents; Swabs | Actinomyces spp.; Bacteroides spp.; Bordetella spp.; Corynebacterium spp.; Enterobacter spp.; Escherichia coli; Fusobacterium spp.; Haemophilus spp.; Klebsiella spp.; Pasteurella spp.; Staphylococcus spp.; Streptococcus spp.; Identification of unknown bacteria | Biochemical; Commercial identification kit; Microscopic examination; Polymerase chain reaction (PCR); Staining | in-house method TM-050 (Alimentary) | |
Foetal specimens; Genital specimens; Milk; Preputial swabs; Preputial wash; Prostatic fluid; Semen; Swabs; Uterine samples | Actinomyces pyogenes; Brucella canis; Brucella ovis; Brucella suis; Campylobacter fetus ss. fetus; Campylobacter fetus; Candida albicans; Clostridium spp.; Corynebacterium renale; Corynebacterium spp.; Escherichia coli; Haemophilus spp.; Klebsiella spp.; Leptospira interrogans; Nocardia spp.; Pasteurella spp.; Pseudomonas spp.; Staphylococcus aureus; Staphylococcus spp.; Streptococcus equi ss. zooepidemicus; Streptococcus - Alpha-haemolytic; Streptococcus - Beta-haemolytic; Streptococcus group D; Identification of unknown bacteria | Biochemical; Commercial identification kit; Cultural; Microscopic examination; Staining | in-house method TM-050 (Genital) | |
Milk; Swabs; Tissues | Brucella abortus; Brucella canis; Brucella ovis; Brucella spp.; Brucella suis; Identification of unknown bacteria | Biochemical; Commercial identification kit; Cultural; Microscopic examination; Staining | in-house methods TM-004 and TM-050 | |
Tissues; Whole blood | Bacillus anthracis | Biochemical; Commercial identification kit; Cultural; Microscopic examination; Staining | in-house method TM-050 | |
Detection and identification of bacteriaFor production animals | Milk | Identification of bacteria causing mastitis | Biochemical; Commercial identification kit; Cultural; Microscopic examination; Staining | in-house method TM-050 |
Detection and identification of bacteriaFor production avian species | Faeces; Intestinal contents; Swabs; Tissues | Salmonella spp. | Biochemical; Commercial identification kit; Microscopic examination | in-house method TM-206 |
Detection and identification of fungi and moulds | Fungal isolates | Identification of unknown fungi | MALDI-TOF | in-house methods TM-050; TM-214 |
Detection and identification of fungi and mouldsFor companion animals, production animals, production avian species, zoo animals, wildlife, equine species and avian species | Fluids; Hair; Nails; Scabs; Skin; Swabs; Tissues | Candida spp.; Cryptococcus spp.; Dermatophytes; Identification of unknown fungi | Cultural; Microscopic examination; Staining | in-house method TM-050 |
Detection and identification of other microorganismsFor companion animals, production animals, production avian species, zoo animals, wildlife, equine species and avian species | Bone; Swabs; Synovial fluid | Mycoplasma spp. | Biochemical; Commercial identification kit; Cultural; Microscopic examination; Staining | in-house method TM-050 (Skeletal) |
Brain tissue; Cerebrospinal fluid (CSF); Conjunctiva; Corneal material; Spinal cord | Mycoplasma spp. | Biochemical; Commercial identification kit; Cultural; Microscopic examination; Staining | in-house method TM-050 (Nervous) | |
Bronchial washings; Lung; Swabs; Tracheal washes | Mycoplasma spp. | Biochemical; Commercial identification kit; Cultural; Microscopic examination; Staining | in-house method TM-050 (Respiratory) (swabs - nasal and sinus) | |
Faeces; Intestinal contents; Swabs | Mycoplasma spp. | Biochemical; Commercial identification kit; Microscopic examination; Polymerase chain reaction (PCR); Staining | in-house method TM-050 (Alimentary) (oral and pharyngeal swabs) | |
Foetal specimens; Genital specimens; Milk; Preputial swabs; Prostatic fluid; Semen; Swabs; Uterine samples | Mycoplasma spp. | Biochemical; Commercial identification kit; Cultural; Microscopic examination; Staining | in-house method TM-050 (Genital) (swabs - vaginal and uterine) |
ISO/IEC 17025 (2017)
Healthcare, Pharmaceutical and Media Products
Service | Product | Determinant | Technique | Procedure |
---|---|---|---|---|
Testing for sterility and freedom from contamination of biological materials intended for veterinary use - Innocuity | Raw materials of animal origin | Brucella abortus; Brucella canis; Brucella melitensis; Brucella suis; Contagious agalactia (Mycoplasma agalactiae); Contagious bovine pleuropneumonia (Mycoplasma mycoides); Contagious caprine pleuropneumonia (Mycoplasma capricolum ss. capripneumoniae, previously F38 mycoplasma); Contagious equine metritis (Taylorella equigenitalis); Contagious pustular dermatitis (Orf); Ornithobacterium rhinotracheale; Exclusion of Mycoplasma; Exclusion of fungi | Bacterial culture - Biphasic medium, mycoplasma broth; PCR - 16S Universal | European Pharmacopoeia, USDA 9CFR regulations, OIE Chapter 1.1.9; DAWE review of Published Tests to Detect Pathogens in Veterinary Vaccines intended for Importation into Australia, Second Edition March 2013; in-house methods TM-050, TM-206, TM-004, TM-021, TM-200. |
ISO/IEC 17025 (2017)
Animal Health
Service | Product | Determinant | Technique | Procedure |
---|---|---|---|---|
Detection and identification of virusesFor companion animals, production animals, production avian species, laboratory animals, zoo animals, wildlife, aquatic animals, equine species and avian species | Allantoic fluid; Culture materials; Faeces; Fluids; Swabs; Urine | Identification of unknown viruses | Electron microscopy (EM) - Negative staining; Electron microscopy (EM) - Thin section analysis; Transmission electron microscopy (TEM) | in-house methods TM-014 and TM-013 |
ISO/IEC 17025 (2017)
Human Pathology
Service | Product | Determinant | Technique | Procedure | Limitations |
---|---|---|---|---|---|
Microbiology - Bacteriology - Detection of pathogenic bacteria | Bacterial cultures from human specimens | Brucella biotype | Agglutination | in-house method TM-004 | |
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Fresh and/or frozen central nervous tissue (including brain, spinal cord and/or salivary glands) | Hendra virus | Roche Taqman RT PCR | in-house method TM-053 | |
Rabies and rabies related lyssaviruses | Rabies and Lyssaviruses conventional PCR | in-house method TM-043 | |||
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Cerebrospinal fluid (CSF); Serum | Hendra virus | Fluorescent antibody virus neutralisation test; Serum neutralisation | in-house method TM-076 | |
Nipah virus | Fluorescent antibody virus neutralisation test; Serum neutralisation | in-house method TM-098 | |||
Rabies related lyssaviruses | Fluorescent antibody virus neutralisation test; Serum neutralisation | in-house method TM-104 | |||
Microbiology - Virology - Detection of pathogenic viruses | Brain tissue; Cerebrospinal fluid (CSF); Salivary gland; Serum; Skin | Rabies virus; Rabies related lyssaviruses | Fluorescent antibody test; Virus isolation | in-house method TM-173 |
ISO/IEC 17025 (2017)
Animal Health
Service | Product | Determinant | Technique | Procedure |
---|---|---|---|---|
Detection and identification of virusesFor avian species | Allantoic fluid; Faeces; Swabs; Tissues | Pigeon paramyoxovirus | PCR - Quantitative (qPCR) | in-house method TM-057 |
Detection and identification of virusesFor companion animals, production animals, production avian species, aquatic animals, equine species and avian species | Brain tissue; Culture materials; Serum; Tissues | Rabies | PCR - Hemi-nested | in-house method TM-043 |
Detection and identification of virusesFor companion animals, production animals, production avian species, zoo animals, wildlife, equine species and avian species | Allantoic fluid; Faeces; Swabs; Tissues | Avian influenza type A; Influenza virus | PCR - Quantitative (qPCR) | in-house method TM-046 |
Culture materials | Australian bat lyssavirus (ABLV) | PCR - Quantitative (qPCR) | in-house method TM-045 | |
Culture materials; Faeces; Swabs; Tissues | Newcastle disease virus (NDV) | PCR - Quantitative (qPCR); Polymerase chain reaction (PCR) | in-house method TM-041 | |
Detection and identification of virusesFor equine species | Allantoic fluid; Faeces; Swabs; Tissues | Hendra virus; Nipah virus | PCR - Quantitative (qPCR); Polymerase chain reaction (PCR) | in-house method TM-053 |
Swabs; Tissues | Equine influenza virus H3 gene | PCR - Quantitative (qPCR) | in-house method TM-048 | |
Detection and identification of virusesFor production animals (cloven hoofed) | Skin | Foot and mouth disease virus (FMD) | PCR - Quantitative (qPCR) - Reverse transcription; Polymerase chain reaction (PCR) | in-house method TM-044 |
Detection and identification of virusesFor production animals (porcine) | Erythrocytes (red blood cells, RBC); Serum; Swabs; Tissues | African swine fever (ASF) virus | PCR - Quantitative (qPCR) | in-house method TM-204 |
Detection and identification of virusesFor production animals | Allantoic fluid; Culture materials; Tissues; Whole blood | Bluetongue virus (BTV) | Genotyping; PCR - Quantitative (qPCR); Polymerase chain reaction (PCR) | in-house methods TM-051 |
Molecular analysis - Bioinformatic analysis and interpretation | DNA sequences | Tertiary analysis - Data annotation and interpretation | Bioinformatics pipeline; Comparison of aligned sequences to database of reference sequences; Conversion of raw data to BAM files; DNA alignment to reference sequence; Mapping of aligned sequences to custom database of verified sequences; Single nucleotide polymorphism (SNP) alignment to scoring notes | in-house methods TM-043 and TM-053 |
Molecular analysis - Sequencing | PCR product | Hendra virus nucleotide sequence - M gene; Hendra virus nucleotide sequence - P gene; Lyssavirus genotype; Lyssavirus sequence identity | Polymerase chain reaction (PCR) | in-house methods TM-043 and TM-053 |
ISO/IEC 17025 (2017)
Animal Health
Service | Product | Determinant | Technique | Procedure |
---|---|---|---|---|
Examination of biopsy material | Tissues | Histological examination | Histopathology; Immunohistochemistry; Macroscopic examination; Microscopic examination | in-house methods TM-019 and TM-018 |
Examination of biopsy materialFor production animals (bovine, caprine and ovine) | Tissues | Prion disease lesions | Immunohistochemistry; Microscopic examination | in-house method TM-019 and TM-225, Australian and New Zealand Standard Diagnostic Procedure, Transmissible Spongiform Encephalopathies, August 2010. |
Necropsy services | Body; Tissues | Gross pathology and collection of sub-samples | Anatomical pathology; Microscopic examination | in-house method TM-017 |
ISO/IEC 17025 (2017)
Animal Health
Service | Product | Determinant | Technique | Procedure |
---|---|---|---|---|
Molecular analysis - Bioinformatic analysis and interpretation | DNA sequences | Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Reporting; Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation | Analysis of DNA alignment; Comparison of aligned sequences to database of reference sequences; DNA alignment to reference sequence | in-house method TM-058, TM-042, TM-190 |
Molecular analysis - Sequencing | Extracted DNA | Newcastle disease sequence identity - Fusion (F) gene sequence pathotyping | Sanger sequencing | in-house method TM-042 |
Bluetongue virus VP3 | Sanger sequencing | in-house method TM-190 | ||
Influenza A virus pathotyping; Influenza A virus subtyping | Sanger sequencing | in-house method TM-058 |
ISO/IEC 17025 (2017)
Animal Health
Service | Product | Determinant | Technique | Procedure |
---|---|---|---|---|
Analysis for transmissible animal diseases under the European Union Directives for Animal Health | Ovine reproductive material | Epizootic haemorrhagic disease virus | Enzyme linked immunosorbent assay (ELISA); Serum neutralisation | OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 3.1.7 (2018) Epizootic haemorrhagic disease |
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Serum | Ehrlichia canis | Enzyme linked immunosorbent assay (ELISA) | in-house method TM-198, EUROIMMUN Anti-Ehrlichia canis ELISA Dog (IgG) kit |
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitationFor avian species and production avian species | Serum | Salmonella enterica serovar Gallinarum biovar Gallinarum; Salmonella enterica serovar Gallinarum biovar Pullorum | Serum agglutination | in-house method TM-074 |
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitationFor avian species | Serum | Avian pneumovirus | Enzyme linked immunosorbent assay (ELISA) | in-house method TM-103 (IDEXX Avian pneumovirus antibody test) |
Newcastle disease virus (NDV) | Haemagglutination inhibition | in-house method TM-080 | ||
Salmonella group D | Enzyme linked immunosorbent assay (ELISA) | in-house method TM-108 (Biochek Salmonella group D antibody test kit) | ||
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitationFor avian, equine and porcine species | Serum | Influenza A virus | Enzyme linked immunosorbent assay (ELISA) | in-house method TM-078 |
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitationFor companion animals (canine) | Serum | Ehrlichia canis | Indirect fluorescent antibody | in-house method TM-119 |
Leishmania spp. | Indirect fluorescent antibody | in-house methods TM-105 | ||
Brucella canis | Serum agglutination | in-house method TM-073 | ||
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitationFor companion animals and production animals | Serum | Rabies | Fluorescent antibody virus neutralisation test | in-house method TM-104 |
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitationFor companion animals, production animals, production avian species, zoo animals, wildlife, equine species and avian species | Serum | Brucella abortus | Complement fixation test (CFT) | in-house method TM-062 |
Trypanosoma evansi | Serum agglutination | in-house method TM-089 (card agglutination) | ||
Leptospira canicola antibody | Microscopic agglutination | in-house method TM-092 | ||
Suid herpesvirus 1 (Aujeszky's disease virus) | Serum neutralisation | in-house method TM-059, OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 3.1.2 (2018) Aujeszky's Disease | ||
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitationFor companion animals, production animals, zoo animals, wildlife | Serum | African swine fever (ASF) virus | Enzyme linked immunosorbent assay (ELISA) | in house method ( INgezim PPA Compac) TM-212 |
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitationFor equine species, companion animals and wildlife (bat) | Serum | Hendra virus | Enzyme linked immunosorbent assay (ELISA) | in-house method TM-123 |
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitationFor equine species | Serum | Hendra virus soluble G | Enzyme linked immunosorbent assay (ELISA) | in-house method TM-110 |
West Nile virus | Enzyme linked immunosorbent assay (ELISA) | in-house method TM-109 | ||
Equine infectious anaemia virus | Agar gel immunodiffusion (AGID) | in-house method TM-066 (VMRD Equine Infectious Anemia Virus Antibody test kit) | ||
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitationFor production animals (bovine, caprine, ovine, porcine) | Serum | Foot and mouth disease virus (FMD) | Enzyme linked immunosorbent assay (ELISA) | in-house methods TM-089 (in-house competition ELISA), TM-121 (PrioCHECK FMDV NS test kit - cattle, sheep, pigs and goats only), TM-067 (in-house liquid phase blocking ELISA) and TM-102 (in-house competition ELISA for the detection of antibodies to FMDV 3ABC non-structural protein) |
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitationFor production animals (porcine) | Serum | Nipah virus | Enzyme linked immunosorbent assay (ELISA) | in-house method TM-097 |
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitationFor production animals and equine species | Serum | Japanese encephalitis virus (JEV); Kunjin virus; Murray Valley encephalitis virus | Plaque reduction test | in-house method TM-095 |
Vesicular stomatitis virus | Serum neutralisation | in-house method TM-072 | ||
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitationFor production animals, avian species, production avian species and equine species | Serum | Avian influenza; Equine influenza virus; Swine influenza virus | Haemagglutination inhibition | in-house method TM-101 |
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitationFor production animals, equine species | Serum | Japanese encephalitis virus (JEV) | Enzyme linked immunosorbent assay (ELISA) | in-house method TM-093 (OIE) |
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitationFor production animals | Serum | Bovine viral diarrhoea virus (BVDV) | Serum neutralisation | in-house method TM-063 |
Porcine epidemic diarrhoea virus | Enzyme linked immunosorbent assay (ELISA) | in-house method TM-120 (IDVet test kit) | ||
Maedi visna virus (MVV) | Agar gel immunodiffusion (AGID) | in-house method TM-087 (Maeditect AHVLA Antibody test kit) | ||
Classical swine fever virus (CSF) | Enzyme linked immunosorbent assay (ELISA) | in-house method TM-112 (IDEXX test kit) | ||
Infectious bursal disease virus | Enzyme linked immunosorbent assay (ELISA) | in-house method TM-079 | ||
Porcine reproductive and respiratory syndrome virus (PRRS) | Immunoperoxidase antibody detection test | in-house method TM-070 | ||
Porcine reproductive and respiratory syndrome virus (PRRS) | Enzyme linked immunosorbent assay (ELISA) | in-house method TM-071 (IDEXX PRRS X3 test kit) | ||
Classical swine fever virus (CSF) | Fluorescent antibody virus neutralisation test; Neutralising peroxidase linked assay | in-house method TM-069, OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals Chapter 3.8.3 (2019) - Classical Swine Fever | ||
African swine fever (ASF) virus | Indirect fluorescent antibody | in-house method TM-124 | ||
Brucella abortus antibody | Enzyme linked immunosorbent assay (ELISA) | in-house method TM-061 | ||
Bovine ephemeral fever virus | Serum neutralisation | in-house method TM-082 | ||
Brucella abortus | Rose Bengal plate; Serum agglutination | in-house method TM-122, OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 3.1.4 (2018) Brucellosis | ||
Bluetongue virus (BTV) | Enzyme linked immunosorbent assay (ELISA) | in-house method TM-083 | ||
Epizootic haemorrhagic disease virus | Serum neutralisation | in-house method TM-068 | ||
Flavivirus group | Enzyme linked immunosorbent assay (ELISA) | in-house method TM-090 | ||
Suid herpesvirus 1 (Aujeszky's disease virus) | Enzyme linked immunosorbent assay (ELISA) | in-house method TM-114 (IDEXX Pseudorabies virus gB antibody ELISA test kit) | ||
Bluetongue virus (BTV) | Serum neutralisation | in-house method TM-084, OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 3.1.3 (2014) Bluetongue (infection with bluetongue virus) | ||
Caprine arthritis encephalitis virus; Maedi visna virus (MVV) | Enzyme linked immunosorbent assay (ELISA) | in-house method TM-096 | ||
Schmallenburg virus | Serum neutralisation | in-house method TM-111 | ||
Infectious bovine rhinotracheitis (IBR) | Serum neutralisation | in-house method TM-100, OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 3.4.11 (2017) - Infectious Bovine Rhinotracheitis/Infectious Pustular Vulvovaginitis | ||
Akabane virus | Serum neutralisation | in-house method TM-081 | ||
Aino virus | Serum neutralisation | in-house method TM-094 | ||
Epizootic haemorrhagic disease virus | Enzyme linked immunosorbent assay (ELISA) | in-house method TM-085 | ||
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitationFor production avian species | Serum | Influenza A virus | Enzyme linked immunosorbent assay (ELISA) | in-house method TM-192 (IDEXX Influenza A virus antibody test kit) |
ISO/IEC 17025 (2017)
Animal Health
Service | Product | Determinant | Technique | Procedure |
---|---|---|---|---|
Detection and identification of viruses | Culture materials; Erythrocytes (red blood cells, RBC); Faeces; Fluids; Semen; Serum; Swabs; Tissues; Urine; Whole blood | Foot and mouth disease virus (FMD) | Cell culture; Cultural | in-house method TM-068 |
Detection and identification of virusesFor companion animals (canine), production animals (porcine), equine species, avian species, zoo animals and wildlife. | Allantoic fluid; Swabs; Tissues | Avian influenza; Avian paramyxovirus (APMV); Equine influenza virus; Newcastle disease virus (NDV); Pigeon paramyoxovirus; Swine influenza virus | Embryonated egg culture; Haemagglutination inhibition | in-house methods TM-163 and TM-170 |
Detection and identification of virusesFor companion animals, production animals, production avian species, zoo animals, wildlife, aquatic animals, equine species and avian species | Brain tissue; Cerebrospinal fluid (CSF); Salivary gland; Serum; Skin; Tissues | Australian bat lyssavirus (ABLV); Rabies | Cell culture; Cultural; Indirect fluorescent antibody | in-house method TM-173 |
Tissues; Whole blood | Bluetongue virus (BTV) | Embryonated egg culture | in-house method TM-161 (Intravenous inoculation) | |
Detection and identification of virusesFor companion animals, production animals, production avian species, zoo animals, wildlife | Culture materials; Fluids; Tissues | Foot and mouth disease virus serotype A; Foot and mouth disease virus serotype Asia1; Foot and mouth disease virus serotype C; Foot and mouth disease virus serotype O; Foot and mouth disease virus serotype SAT1; Foot and mouth disease virus serotype SAT2; Foot and mouth disease virus serotype SAT3; Swine vesicular disease virus; Vesicular stomatitis virus | Enzyme linked immunosorbent assay (ELISA) | in-house method TM-165, OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 3.1.8 (2017) Foot and mouth disease |
Detection and identification of virusesFor production animals | Culture materials; Erythrocytes (red blood cells, RBC); Faeces; Fluids; Semen; Serum; Swabs; Tissues; Urine; Whole blood | Akabane virus; Australian bat lyssavirus (ABLV); Bovine ephemeral fever virus; Classical swine fever virus (CSF); Equine arteritis virus; Foot and mouth disease virus (FMD); Hendra virus; Japanese encephalitis virus (JEV); Murray Valley encephalitis virus; Pestivirus; Porcine circovirus; Porcine parvovirus; Porcine reproductive and respiratory syndrome virus (PRRS); Ross River virus IgG antibody; West Nile virus; Border disease; Identification of unknown viruses; Rabies; Transmissible gastroenteritis (TGE) | Cell culture; Cultural | in-house method TM-167 |
Detection and identification of virusesFor production avian species | Swabs; Tissues | Infectious bursal disease virus | Embryonated egg culture | in-house method TM-162 (Chorioallantoic membrane inoculation) |
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitationFor companion animals, production animals, production avian species, zoo animals, wildlife, equine species and avian species | Serum | Nipah virus | Serum neutralisation | in-house method TM-098 |
Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitationFor equine species, companion animals and wildlife | Serum | Hendra virus | Serum neutralisation | in-house method TM-076 |
ISO/IEC 17025 (2017)
Healthcare, Pharmaceutical and Media Products
Service | Product | Determinant | Technique | Procedure |
---|---|---|---|---|
Testing for sterility and freedom from contamination of biological materials intended for veterinary use - Innocuity | Raw materials of animal origin | Anatid herpesvirus (duck viral enteritis); Avian influenza; Infectious bursal disease virus; Turkey rhinotracheitis virus | Embryonated egg culture; Haemagglutination; Virus isolation | European Pharmacopoeia, USDA 9CFR regulations, OIE Chapter 1.1.9; DAWE review of Published Tests to Detect Pathogens in Veterinary Vaccines intended for Importation into Australia, Second Edition March 2013; in-house methods TM-162, TM-163, TM-168, TM-170, TM-020, TM-021, TM-200. |
African horse sickness virus; African swine fever (ASF) virus ; Akabane virus; Bluetongue virus (BTV); Border disease virus; Bovine ephemeral fever virus; Bovine herpes mammillitis virus (BHV-2); Bovine herpes virus type 4 (Movar virus); Bovine herpes virus type 1; Bovine parvovirus; Bovine respiratory syncytial virus; Bovine rotavirus; Bovine viral diarrhoea virus (BVDV); Canine adenovirus 1; Canine adenovirus 2; Canine distemper virus; Canine parvovirus; Caprine arthritis encephalitis virus; Classical swine fever virus (CSF); Epizootic haemorrhagic disease virus; Equine adenovirus; Equine arteritis virus; Equine encephalomyelitis virus; Equine herpes virus type 1; Equine herpes virus type 2; Equine herpes virus type 3; Equine herpes virus type 4; Equine influenza virus; Feline calicivirus; Feline panleukopenia virus; Feline rhinotracheitis virus; Foot and mouth disease virus (FMD); Haemagglutinating encephalomyelitis virus; Infectious bronchitis virus; Japanese encephalitis virus (JEV); Parainfluenza virus type 3; Peste des petits ruminants virus (PPRV, Ovine rinderpest); Porcine adenovirus; Porcine circovirus type 1; Porcine circovirus type 2; Porcine enterovirus; Porcine epidemic diarrhoea virus; Porcine parvovirus; Porcine rotavirus; Rabies virus; Rift Valley fever virus; Suid herpesvirus 1 (Aujeszky's disease virus); Swine influenza virus; Swine pox virus; Swine vesicular disease virus; Transmissible gastroenteritis virus; Vesicular stomatitis virus; West Nile virus | Embryonated egg culture; Enzyme linked immunosorbent assay (ELISA); Fluorescent antibody test; Indirect fluorescent antibody; Virus isolation | European Pharmacopoeia, USDA 9CFR regulations, OIE Chapter 1.1.9; DAWE review of Published Tests to Detect Pathogens in Veterinary Vaccines intended for Importation into Australia, Second Edition March 2013; in-house methods TM-161, TM-167, TM-173, TM-020, TM-209, TM-215, TM-216, TM 217 |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
13546
Site No.
13539
Print date
26 Jan 2025